Position in RCKT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$243,604
-$116,304 QoQ
Shares Held
68,046
-33.6% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCKT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TD Asset Management Inc holds $1,314,505,240 across 121 Biotechnology names. RCKT ranks #116 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
350,923 | $271,137,146 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
228,195 | $101,898,194 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
281,848 | $93,255,047 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,168,666 | $75,530,883 | |
| 5 | ARGX |
Argenx SE
|
80,824 | $59,021,726 | |
| 6 | ASND |
Ascendis Pharma A/S
|
217,992 | $49,861,310 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
529,954 | $39,794,245 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
317,811 | $30,907,119 |
All Filings in RCKT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $243,604 | 68,046 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $359,908 | 102,538 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $334,273 | 102,538 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $428,529 | 174,910 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,085,275 | 162,710 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,243,166 | 178,454 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,280,456 | 177,610 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $3,835,870 | 178,164 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $4,180,118 | 155,164 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $4,641,274 | 154,864 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,295,494 | 112,030 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,113,018 | 56,015 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $683,743 | 39,915 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $826,147 | 42,215 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $529,105 | 33,152 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $910,678 | 66,183 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,049,662 | 66,183 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,444,774 | 66,183 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,477,372 | 82,883 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,670,888 | 82,883 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $3,945,957 | 88,933 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,355,612 | 79,424 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,418,760 | 62,063 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $820,560 | 39,205 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $546,909 | 39,205 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||